HIK — Hikma Pharmaceuticals Share News
0.000.00%
- £4.39bn
- £5.20bn
- $3.16bn
- 90
- 45
- 87
- 90
REG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Additional Listing
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Hikma launches sodium oxybate in the US
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Hikma Injectables Portugal site visit
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Directorate Change
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Block listing Interim Review
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Director changes and update on AGM 2022 resolution
AnnouncementREG - Hikma Pharmaceutical - Change of Hikma interim dividend payment date
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
Announcement